Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years
- PMID: 11100280
- DOI: 10.1038/sj.bmt.1702654
Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years
Abstract
Invasive fungal infections (IFI) with substantial mortality constitute an increasing problem among BMT patients. From 1986 to 1996 148 children underwent BMT, and are included in a retrospective analysis of the incidence, risk factors and outcome of IFI. By histopathology or culture-proven IFI (Candida, 10; Aspergillus, 8) was documented in 12/73 (16%) allogeneic and in 6/75 (8%) autologous BMT patients. Of these 18 patients, 15 subsequently died, and in 12 (66%) IFI was regarded as the main cause of death. In addition to the patients with documented IFI, 48 had suspected and 82 no fungal infection. Invasive candidal infections were more frequent in patients with semiquantitatively estimated abundant candidal colonization as compared with those with no colonization (18% vs 3%, P = 0.015). In the allogeneic group, 50% of those with severe (grades III-IV) aGVHD had IFI as opposed to 8% of those with no or mild aGVHD (P < 0.001). Regarding cGVHD, 57% of those with extensive cGVHD vs 5% of those with absent or limited cGVHD had IFI (P < 0.001). The dose of steroids was associated with IFI: 77% of those who received high-dose steroids (methylprednisolone 0.25-1 g/day for 5 days) vs 5% of those with conventional-dose (prednisone 2 mg/kg/day) had IFI (P < 0.001). Particularly for BMT patients at risk, new, quicker and better diagnostic tests and more effective anti-fungal agents, both for prophylaxis and treatment, are needed.
Similar articles
-
Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.Bone Marrow Transplant. 2005 Oct;36(7):621-9. doi: 10.1038/sj.bmt.1705113. Bone Marrow Transplant. 2005. PMID: 16044133
-
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.Bone Marrow Transplant. 2000 Nov;26(9):993-7. doi: 10.1038/sj.bmt.1702655. Bone Marrow Transplant. 2000. PMID: 11100279 Clinical Trial.
-
Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients.Bone Marrow Transplant. 1997 Apr;19(8):801-8. doi: 10.1038/sj.bmt.1700737. Bone Marrow Transplant. 1997. PMID: 9134172
-
Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.Bone Marrow Transplant. 1999 Feb;23(3):271-5. doi: 10.1038/sj.bmt.1701562. Bone Marrow Transplant. 1999. PMID: 10084259 Review.
-
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.Eur J Haematol. 2007 Apr;78(4):275-82. doi: 10.1111/j.1600-0609.2006.00805.x. Epub 2007 Jan 23. Eur J Haematol. 2007. PMID: 17241370 Review.
Cited by
-
Impact of dexamethasone on transplant-related mortality in pediatric patients: a multi-site, propensity score-weighted, retrospective assessment.Support Care Cancer. 2024 Jul 25;32(8):552. doi: 10.1007/s00520-024-08732-8. Support Care Cancer. 2024. PMID: 39052128
-
A population pharmacokinetic model for posaconazole intravenous solution and oral powder for suspension formulations in pediatric patients with neutropenia.Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0119723. doi: 10.1128/aac.01197-23. Epub 2024 Feb 20. Antimicrob Agents Chemother. 2024. PMID: 38376229 Free PMC article. Clinical Trial.
-
INVASIVE FUNGAL INFECTIONS IN CHILDREN TREATED FOR HEMATOLOGIC MALIGNANCIES - A FIVE-YEAR SINGLE CENTER EXPERIENCE.Acta Clin Croat. 2022 Dec;61(4):647-654. doi: 10.20471/acc.2022.61.04.11. Acta Clin Croat. 2022. PMID: 37868174 Free PMC article.
-
Infections and risk factors for infection-related mortality after pediatric allogeneic hematopoietic stem cell transplantation in Mexico: A single center retrospective study.PLoS One. 2023 Sep 29;18(9):e0284628. doi: 10.1371/journal.pone.0284628. eCollection 2023. PLoS One. 2023. PMID: 37773955 Free PMC article.
-
Prospective Study on Prophylactic Micafungin Sodium against Invasive Fungal Disease during Neutropenia in Pediatric & Adolescent Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation.Children (Basel). 2022 Mar 7;9(3):372. doi: 10.3390/children9030372. Children (Basel). 2022. PMID: 35327744 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical